Zum Thema Leberzellkrebs:
Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression. Apostolidis L, Pfeiffenberger J, Gotthardt D, Radeleff B, Mehrabi A, Schemmer P, Jäger D, Schirmacher P, Stremmel W, Schulze-Bergkamen H, Springfeld C, Weiss KH. Gastrointest Tumors. 2018 Sep;5(1-2):38-46
Zum Thema Gallenwegskrebs:
An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapy. Köhler BC, Goeppert B, Waldburger N, Schlamp K, Sauer P, Jäger D, Weiss KH, Macher-Göppinger S, Schulze-Bergkamen H, Schirmacher P, Springfeld C., Oncotarget. 2018 Apr 24;9(31):22230-22235.
Zum Thema Brustkrebs:
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study. Dall P, Koch T, Göhler T, Selbach J, Ammon A, Eggert J, Gazawi N, Rezek D, Wischnik A, Hielscher C, Schleif N, Cirrincione U, Hinke A, Feisel-Schwickardi G., BMC Cancer. 2018 Jan 8;18(1):51.
Zum Thema innovative neue Krebsmedikamente:
Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas.
Fiedler W, Cresta S, Schulze-Bergkamen H, De Dosso S, Weidmann J, Tessari A, Baumeister H, Danielczyk A, Dietrich B, Goletz S, Zurlo A, Salzberg M, Sessa C, Gianni L., ESMO Open. 2018 Feb 1;3(2):e000303.
Neueste Publikation der Arbeitsgruppe Prof. Schulze-Bergkamen mit dem NCT Heidelberg (in der international führenden Fachzeitschrift für Magen-Darm-Erkrankungen):
Nuclear Translocation of RELB is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.Elßner C, Goeppert B, Longerich T, Scherr AL, Stindt J, Nanduri LK, Rupp C, Kather JN, Schmitt N, Kautz N, Breuhahn K, Ismail L, Heide D, Hetzer J, García-Beccaria M, Hövelmeyer N, Waisman A, Urbanik T, Mueller S, Gdynia G, Banales JM, Roessler S, Schirmacher P, Jäger D, Schölch S, Keitel V, Heikenwalder M, Schulze-Bergkamen H, Köhler BC., Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35260-0